Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...

Sarcopenia influences toxicity and survival in non-small cell lung cancer, and sarcopenia assessment can be factored into ...

Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.

With this approval, durvalumab can now be used for treating patients with limited-stage small cell lung cancer (LS-SCLC) ...

The advent of concurrent chemoradiation has significantly contributed to the curability of head and neck cancer, including locoregionally advanced disease. Preserving organ function and reducing ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...

AstraZeneca Pharma India gets CDSCO nod for durvalumab to treat LS-SCLC: Our Bureau, Bengaluru Monday, March 10, 2025, 15:30 Hrs [IST] AstraZeneca Pharma India, received a Central ...

Data from the Phase II trial saw three of the seven patients dosed with CAN-2409 surviving for more than 35 months.

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

Diversion surgery before chemoradiation may be considered for patients with intestinal obstruction or other symptoms that could compromise their likelihood of completing definitive treatment.

Diversion surgery before chemoradiation may be considered for patients with intestinal obstruction or other symptoms that could compromise their likelihood of completing definitive treatment. The ...